DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Paclitaxel (Paclitaxel) - Fatigue - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Fatigue (171)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Paclitaxel where reactions include fatigue. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 171   Next >>

Possible Paclitaxel side effects in 73 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-21

Patient: 73 year old male, weighing 62.0 kg (136.4 pounds)

Reactions: Fatigue, Dyspnoea

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Paclitaxel

Other drugs received by patient: Ranitidine; Granisetron; Dexamethasone; Omeprazole; Perindopril Erbumine; Enoxaparin Sodium; Promethazine



Possible Paclitaxel side effects in female

Reported by a physician from Ireland on 2012-08-21

Patient: female, weighing 45.0 kg (99.0 pounds)

Reactions: Weight Decreased, Fatigue, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: 5 mg, unk
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2011-02-04
    End date: 2011-05-30

Comparator Trastuzumab
    Dosage: 90 mg, weekly
    Indication: Breast Cancer Metastatic
    Start date: 2011-02-04

Paclitaxel
    Dosage: 90 mg, weekly
    Start date: 2011-02-04
    End date: 2011-05-27

Paclitaxel
    Dosage: 60 mg/m2
    Start date: 2011-03-18
    End date: 2011-04-15

Other drugs received by patient: Lipitor; Micardis; Pantoprazole; Acetaminophen; Pantoprazole; Valoid



Possible Paclitaxel side effects in female

Reported by a physician from Germany on 2012-08-20

Patient: female, weighing 62.0 kg (136.4 pounds)

Reactions: Fatigue, Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bevacizumab
    Indication: Breast Cancer
    Start date: 2012-05-18
    End date: 2012-08-09

Carboplatin
    Indication: Breast Cancer
    Start date: 2012-05-18
    End date: 2012-08-09

Doxorubicin HCL
    Indication: Breast Cancer
    Start date: 2012-05-18
    End date: 2012-08-09

Paclitaxel
    Indication: Breast Cancer
    Start date: 2012-05-18
    End date: 2012-08-09



Possible Paclitaxel side effects in

Reported by a individual with unspecified qualification from United States on 2012-08-20

Patient: , weighing 84.8 kg (186.6 pounds)

Reactions: Fatigue, Pleural Effusion, Acute Respiratory Distress Syndrome, Rash, Asthenia

Drug(s) suspected as cause:
Carboplatin
    Start date: 2012-02-06

Paclitaxel
    Start date: 2012-02-13

Other drugs received by patient: Potassium; Verapamil; Reglan



Possible Paclitaxel side effects in

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-08-20

Patient:

Reactions: Abdominal Pain, Vomiting, Hypersensitivity, Nausea, Skin Toxicity, Mucosal Inflammation, Fatigue, Diarrhoea, Hepatotoxicity, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Breast Cancer

Epirubicin
    Indication: Breast Cancer

Fluorouracil
    Indication: Breast Cancer

Herceptin
    Dosage: loading dose
    Indication: Breast Cancer

Herceptin
    Dosage: maintenance dose

Lapatinib
    Dosage: arm b
    Administration route: Oral
    Indication: Breast Cancer

Lapatinib
    Dosage: arm c
    Administration route: Oral

Paclitaxel
    Indication: Breast Cancer



Possible Paclitaxel side effects in female

Reported by a physician from Germany on 2012-08-09

Patient: female, weighing 62.0 kg (136.4 pounds)

Reactions: Fatigue

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bevacizumab
    Indication: Breast Cancer
    Start date: 2012-05-18

Carboplatin
    Indication: Breast Cancer
    Start date: 2012-05-18

Doxorubicin HCL
    Indication: Breast Cancer
    Start date: 2012-05-18

Paclitaxel
    Indication: Breast Cancer
    Start date: 2012-05-18



Possible Paclitaxel side effects in 75 year old female

Reported by a physician from United States on 2012-08-02

Patient: 75 year old female, weighing 49.7 kg (109.4 pounds)

Reactions: Activated Partial Thromboplastin Time Prolonged, Fatigue, Hypocalcaemia, White Blood Cell Count Decreased, Vomiting, Nausea, Hypotension, Renal Failure Chronic, Hypophosphataemia, Syncope, Respiratory Failure, Embolism, Diarrhoea, Aspartate Aminotransferase Increased, Hypermagnesaemia, Hypoalbuminaemia, Neutrophil Count Decreased, Enterocolitis Infectious

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Avastin
    Dosage: over 30-90 minutes on day 1 of cycles 2+. drug withdrawn.
    Indication: Ovarian Epithelial Cancer
    Start date: 2012-01-31
    End date: 2012-02-21

Carboplatin
    Dosage: auc=6 iv on day 1 (cycle 1-6)
    Indication: Ovarian Epithelial Cancer
    Start date: 2012-01-31

Paclitaxel
    Dosage: over 3 hours on day 1 (cycles, 1-6).
    Indication: Ovarian Epithelial Cancer
    Start date: 2012-01-31



Possible Paclitaxel side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-31

Patient: female

Reactions: Hypophosphataemia, Fatigue, Tinnitus, Clostridium Difficile Colitis, Neutropenia, Thrombocytopenia, Klebsiella Bacteraemia

Drug(s) suspected as cause:
Carboplatin
    Dosage: auc 7 reconstituted with one liter normal saline (day 1;repeated every 21 days),intraperitoneal
    Indication: Ovarian Cancer

Carboplatin
    Dosage: auc 7 reconstituted with one liter normal saline (day 1;repeated every 21 days),intraperitoneal
    Indication: Malignant Peritoneal Neoplasm

Carboplatin
    Dosage: auc 7 reconstituted with one liter normal saline (day 1;repeated every 21 days),intraperitoneal
    Indication: Fallopian Tube Cancer

Paclitaxel
    Dosage: 60 mg/m2 reconstituted with one liter normal saline (day 8; repeated every 21 days),intraperitoneal
    Indication: Ovarian Cancer

Paclitaxel
    Dosage: 60 mg/m2 reconstituted with one liter normal saline (day 8; repeated every 21 days),intraperitoneal
    Indication: Fallopian Tube Cancer

Paclitaxel
    Dosage: 175 mg/m2 (day 1;repeated every 21 days),intravenous
    Indication: Fallopian Tube Cancer

Paclitaxel
    Dosage: 175 mg/m2 (day 1;repeated every 21 days),intravenous
    Indication: Ovarian Cancer



Possible Paclitaxel side effects in 73 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-27

Patient: 73 year old male, weighing 62.0 kg (136.4 pounds)

Reactions: Fatigue, Dyspnoea

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Paclitaxel

Other drugs received by patient: Enoxaparin Sodium; Ranitidine; Granisetron; Omeprazole; Promethazine; Dexamethasone; Perindopril Erbumine



Possible Paclitaxel side effects in 75 year old female

Reported by a physician from United States on 2012-07-24

Patient: 75 year old female, weighing 51.4 kg (113.0 pounds)

Reactions: White Blood Cell Count Decreased, Hypotension, Hypophosphataemia, Activated Partial Thromboplastin Time Prolonged, Fatigue, Diarrhoea, Embolism, Hypermagnesaemia, Hypocalcaemia, Hypoalbuminaemia, Neutrophil Count Decreased, Enterocolitis Infectious

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Avastin
    Dosage: over 30-90 minutres on day 1 of cycles 2+
    Indication: Ovarian Epithelial Cancer
    Start date: 2012-01-31

Carboplatin
    Dosage: auc=6 iv on day 1 (cycle 1-6)
    Indication: Ovarian Epithelial Cancer
    Start date: 2012-01-31

Paclitaxel
    Dosage: over 3 hours on day 1 (cycles, 1-6).
    Indication: Ovarian Epithelial Cancer
    Start date: 2012-01-31



Possible Paclitaxel side effects in 65 year old female

Reported by a physician from Germany on 2012-07-23

Patient: 65 year old female, weighing 46.4 kg (102.1 pounds)

Reactions: Weight Decreased, Fistula, Nausea, Anaemia, General Physical Health Deterioration, Fatigue, Sepsis, Decreased Appetite, Infection

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Avastin
    Indication: Ovarian Cancer
    Start date: 2012-03-21
    End date: 2012-04-18

Avastin
    Dosage: last dose:15/may/2012
    End date: 2012-06-10

Carboplatin
    Dosage: auc 5,
    Indication: Ovarian Cancer
    Start date: 2012-02-27
    End date: 2012-04-18

Carboplatin
    Dosage: auc 5, last dose:15/may/2012
    End date: 2012-06-10

Paclitaxel
    Dosage: last dose:15/may/2012
    Indication: Ovarian Cancer
    Start date: 2012-02-27
    End date: 2012-04-18

Paclitaxel
    Dosage: last dose:15/may/2012
    End date: 2012-06-10

Other drugs received by patient: Novalgin; Pantoprazole; Zolpidem



Possible Paclitaxel side effects in 64 year old female

Reported by a physician from United States on 2012-07-23

Patient: 64 year old female, weighing 102.0 kg (224.4 pounds)

Reactions: Abdominal Pain, Hyponatraemia, Disease Progression, Soft Tissue Infection, Death, Fatigue, Colonic Fistula, Hypermagnesaemia, Hypoalbuminaemia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Avastin
    Indication: Ovarian Epithelial Cancer
    Start date: 2009-12-03

Carboplatin
    Indication: Ovarian Epithelial Cancer
    Start date: 2009-12-03

Paclitaxel
    Indication: Ovarian Epithelial Cancer
    Start date: 2009-12-03



Possible Paclitaxel side effects in female

Reported by a physician from United States on 2012-07-23

Patient: female, weighing 93.0 kg (204.5 pounds)

Reactions: Tooth Loss, Tricuspid Valve Incompetence, Hot Flush, Mood Altered, Iron Deficiency Anaemia, Retinal Pigment Epitheliopathy, Back Pain, Osteopenia, Cervical Dysplasia, Joint Injury, Diverticulum, Metastases To Spine, Compression Fracture, Pancreatitis, Calculus Ureteric, Upper-Airway Cough Syndrome, Adnexa Uteri Cyst, Vitreous Floaters, Hydroureter, Depression, Injury, Decreased Appetite, Vomiting, Cataract, Retinal Melanoma, Lung Neoplasm, Musculoskeletal Pain, Thyroid Cyst, Pulmonary Valve Incompetence, Arthralgia, Oral Pain, Mitral Valve Incompetence, Asthenia, DRY Eye, Abdominal Hernia, Night Sweats, Weight Decreased, Femur Fracture, Metastases To Liver, Nocturia, Headache, Pericardial Effusion, Tendon Injury, Neoplasm Skin, Dyspepsia, Sexually Transmitted Disease, Sinus Congestion, Mastoid Disorder, Intervertebral Disc Protrusion, Hydronephrosis, Hiatus Hernia, Cardiac Murmur, Peptic Ulcer, Anaemia, General Physical Health Deterioration, Renal Cyst, Hypoaesthesia, Atelectasis, Pain, Bone Pain, Conjunctivitis, Nephrolithiasis, Fatigue, Neuropathy Peripheral, Biliary Dyskinesia, Photophobia, Pleural Effusion, Intervertebral Disc Degeneration, Sinusitis, RIB Fracture, Spondylolisthesis, Nausea, Myopia, Anxiety, Osteonecrosis of JAW, Diarrhoea, Oral Disorder, Osteosarcoma Metastatic, Bronchitis, Hypertension, Deep Vein Thrombosis

Drug(s) suspected as cause:
Aredia
    Dosage: 90 mg, unk
    End date: 2001-02-21

Paclitaxel

Zometa
    Dosage: 4 mg, unk
    Indication: Metastases To Bone
    Start date: 2002-03-04
    End date: 2004-09-01

Other drugs received by patient: Lipitor; Cefuroxime Axetil; Vitamin D; Hydrocodone Bitartrate and Acetaminophen; Motrin; Cytoxan; Folate Sodium; Oxycodone HCL; Amoxicillin; Trazodone Hydrochloride; Depo-Medrol; Arimidex; Radiation Therapy; Lupron; Paxil; Sertraline Hydrochloride; Zoloft; Robaxin; Magnesium Sulfate; Alpha Lipoic Acid; Aromasin; Avastin; Femara; Prochlorperazine; Aspirin; Multivitamin ^lappe^; Adriamycin PFS; Anzemet; Fish OIL; Turmeric; Simvastatin; Calcium; Zoladex; Taxotere; Hydrogen Peroxide Mouth Rinse; Methocarbamol; Prilosec; Penicillin VK; Dexamethasone; Clindamycin; Fexofenadine; Taxol; Ethyol; Magace; Pepcid; Lortab; Oophorectomy



Possible Paclitaxel side effects in

Reported by a health professional (non-physician/pharmacist) from Korea, Republic of on 2012-07-19

Patient:

Reactions: Stomatitis, Alanine Aminotransferase Increased, Febrile Neutropenia, Fatigue, Aspartate Aminotransferase Increased, Neutropenia, Thrombocytopenia, Leukopenia, Decreased Appetite

Drug(s) suspected as cause:
Gemcitabine Hydrochloride
    Dosage: on days 1 and 8 every 21 days
    Indication: Breast Cancer

Herceptin
    Dosage: within 2 weeks after curative surgery until 52 weeks of therapy was completed

Herceptin
    Dosage: over 90 min on day 1
    Indication: Breast Cancer

Herceptin
    Dosage: over 30 min weekly

Paclitaxel
    Dosage: over 1 h on days 1 and 8 every 21 days
    Indication: Breast Cancer



Possible Paclitaxel side effects in

Reported by a health professional (non-physician/pharmacist) from Korea, Republic of on 2012-07-18

Patient:

Reactions: Stomatitis, Alanine Aminotransferase Increased, Febrile Neutropenia, Fatigue, Aspartate Aminotransferase Increased, Neutropenia, Thrombocytopenia, Decreased Appetite, Leukopenia

Drug(s) suspected as cause:
Gemcitabine Hydrochloride
    Indication: Breast Cancer

Gemcitabine Hydrochloride
    Dosage: dosages were modified to one step lower than the previous level after withholding treatment

Herceptin
    Dosage: over 90 min on day 1, followed by 2 mg/kg over 30 min weekly, for a total of 18 doses
    Indication: Breast Cancer

Herceptin
    Dosage: after curative surgery until 52 weeks of therapy was completed.

Paclitaxel
    Indication: Breast Cancer

Paclitaxel
    Dosage: dosages were modified to one step lower than the previous level after withholding treatment



Possible Paclitaxel side effects in 64 year old female

Reported by a physician from United States on 2012-07-18

Patient: 64 year old female, weighing 102.0 kg (224.4 pounds)

Reactions: Abdominal Pain, Hyponatraemia, Disease Progression, Death, Soft Tissue Infection, Fatigue, Colonic Fistula, Hypermagnesaemia, Hypoalbuminaemia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Avastin
    Indication: Ovarian Epithelial Cancer
    Start date: 2009-12-03

Carboplatin
    Indication: Ovarian Epithelial Cancer
    Start date: 2009-12-03

Paclitaxel
    Indication: Ovarian Epithelial Cancer
    Start date: 2009-12-03



Possible Paclitaxel side effects in female

Reported by a individual with unspecified qualification from United States on 2012-07-16

Patient: female, weighing 100.9 kg (222.0 pounds)

Reactions: Productive Cough, Blood Pressure Increased, Wheezing, Cystitis Klebsiella, Oropharyngeal Pain, Pyrexia, Respiratory Tract Congestion, Myalgia, Fatigue, Dyspnoea Exertional, Activities of Daily Living Impaired, Impaired Healing

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
G-CSF (Filgrastim, Amgen)
    Dosage: 6 mg

Ifosfamide
    Dosage: 6600 mg

Paclitaxel
    Dosage: 270 mg



Possible Paclitaxel side effects in female

Reported by a physician from Ireland on 2012-07-09

Patient: female, weighing 86.7 kg (190.7 pounds)

Reactions: Fatigue, Diarrhoea, Hyponatraemia, Blood Creatinine Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Lapatinib
    Dosage: 1000mg per day
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2012-05-29

Paclitaxel
    Dosage: 80mgm2 cyclic
    Indication: Breast Cancer Metastatic
    Start date: 2012-05-29

Trastuzumab
    Dosage: 4mgk cyclic
    Indication: Breast Cancer Metastatic
    Start date: 2012-05-29

Other drugs received by patient: Loperamide; Ramipril; Bendroflumethiazide; Aldomet



Possible Paclitaxel side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-02

Patient: female, weighing 120.6 kg (265.3 pounds)

Reactions: Vomiting, Hypersensitivity, Neutrophil Count, Nausea, Anaemia, Constipation, Hypokalaemia, Haemoglobin Decreased, Fatigue, Platelet Count Decreased, Asthenia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Avastin
    Indication: Ovarian Cancer
    Start date: 2012-02-29
    End date: 2012-03-21

Carboplatin
    Dosage: dose: 5 auc
    Start date: 2012-03-21
    End date: 2012-04-11

Carboplatin
    Dosage: dose: 6 auc
    Indication: Ovarian Cancer
    Start date: 2012-02-29
    End date: 2012-04-11

Paclitaxel
    Indication: Ovarian Cancer
    Start date: 2012-02-29
    End date: 2012-04-11

Other drugs received by patient: Palonosetron; Ranitidine; Colace; Dexamethasone; Lovenox; Benadryl; Reglan



Possible Paclitaxel side effects in 75 year old female

Reported by a physician from United States on 2012-07-02

Patient: 75 year old female, weighing 51.4 kg (113.0 pounds)

Reactions: White Blood Cell Count Decreased, Hypotension, Hypophosphataemia, Activated Partial Thromboplastin Time Prolonged, Fatigue, Diarrhoea, Embolism, Hypermagnesaemia, Hypoalbuminaemia, Hypocalcaemia, Neutrophil Count Decreased, Enterocolitis Infectious

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Avastin
    Dosage: over 30-90 minutres on day 1 of cycles 2+
    Indication: Ovarian Epithelial Cancer
    Start date: 2012-01-31

Carboplatin
    Dosage: auc=6 iv on day 1 (cycle 1-6)
    Indication: Ovarian Epithelial Cancer
    Start date: 2012-01-31

Paclitaxel
    Dosage: over 3 hours on day 1 (cycles, 1-6).
    Indication: Ovarian Epithelial Cancer
    Start date: 2012-01-31



Possible Paclitaxel side effects in 75 year old female

Reported by a physician from United States on 2012-06-29

Patient: 75 year old female, weighing 51.4 kg (113.0 pounds)

Reactions: White Blood Cell Count Decreased, Hypotension, Activated Partial Thromboplastin Time Prolonged, Hypophosphataemia, Fatigue, Diarrhoea, Embolism, Hypermagnesaemia, Hypoalbuminaemia, Hypocalcaemia, Neutrophil Count Decreased, Enterocolitis Infectious

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Avastin
    Dosage: over 30-90 minutres on day 1 of cycles 2+
    Indication: Ovarian Epithelial Cancer
    Start date: 2012-01-31

Carboplatin
    Dosage: auc=6 iv on day 1 (cycle 1-6)
    Indication: Ovarian Epithelial Cancer
    Start date: 2012-01-31

Paclitaxel
    Dosage: over 3 hours on day 1 (cycles, 1-6).
    Indication: Ovarian Epithelial Cancer
    Start date: 2012-01-31



Possible Paclitaxel side effects in 48 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-28

Patient: 48 year old female, weighing 31.8 kg (69.9 pounds)

Reactions: Dyspnoea, Chest Discomfort, Fatigue, Chest Pain, Sensation of Pressure

Drug(s) suspected as cause:
(Domperidone)
    Dosage: 20 mg milligram(s), 1 day, oral ; 20 mg, as needed
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Chlorpheniramine Maleate
    Dosage: 10 mg milligram(s) intravenous (not otherwise specified)
    Indication: Product Used FOR Unknown Indication

Dexamethasone
    Dosage: 4 mg milligram(s) oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Dexamethasone
    Dosage: 20 mg milligram(s), intravenous (not otherwise specified)
    Indication: Product Used FOR Unknown Indication

Granisetron
    Dosage: 1 mg milligram(s), 1 day, oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Neulasta
    Dosage: 6 mg milligram(s) subcutaneous
    Indication: Chemotherapy

Paclitaxel
    Dosage: see image
    Indication: Breast Cancer
    Start date: 2011-05-24
    End date: 2011-07-05

Paclitaxel
    Dosage: see image
    Indication: Breast Cancer
    End date: 2011-07-05

Ranitidine
    Dosage: 50 mg milligram(s), intravenous (not otherwise specified)
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: (Docusate); (Biotene / 00203502 / )



Possible Paclitaxel side effects in 65 year old female

Reported by a physician from Germany on 2012-06-28

Patient: 65 year old female, weighing 46.4 kg (102.1 pounds)

Reactions: Weight Decreased, Fistula, Fatigue, Nausea, Sepsis, Anaemia, General Physical Health Deterioration, Decreased Appetite, Infection

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Avastin
    Indication: Ovarian Cancer
    Start date: 2012-03-21
    End date: 2012-04-18

Avastin
    Dosage: last dose:15/may/2012
    End date: 2012-06-10

Carboplatin
    Dosage: auc 5,
    Indication: Ovarian Cancer
    Start date: 2012-02-27
    End date: 2012-04-18

Carboplatin
    Dosage: auc 5, last dose:15/may/2012
    End date: 2012-06-10

Paclitaxel
    Dosage: last dose:15/may/2012
    Indication: Ovarian Cancer
    Start date: 2012-02-27
    End date: 2012-04-18

Paclitaxel
    Dosage: last dose:15/may/2012
    End date: 2012-06-10

Other drugs received by patient: Pantoprazole; Zolpidem; Novalgin



Possible Paclitaxel side effects in female

Reported by a physician from South Africa on 2012-06-27

Patient: female, weighing 52.0 kg (114.4 pounds)

Reactions: Diabetic Ulcer, Hyperglycaemia, Neoplasm Progression, Hyponatraemia, Hypokalaemia, Renal Impairment, Fatigue, Neoplasm Malignant, Skin Lesion, Sepsis, Dehydration, Cardiac Arrest, Pneumonitis

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: unk
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2010-08-10

Comparator Trastuzumab
    Dosage: 2 mg/kg, qw
    Indication: Breast Cancer Metastatic
    Start date: 2010-08-10

Paclitaxel
    Dosage: 80 mg/m2, qw
    Indication: Breast Cancer Metastatic
    Start date: 2010-08-10

Other drugs received by patient: Maxolon; Marinol; Zamanon; Metformin HCL



Possible Paclitaxel side effects in 48 year old female

Reported by a pharmacist from United Kingdom on 2012-06-25

Patient: 48 year old female, weighing 70.0 kg (154.0 pounds)

Reactions: Respiratory Depth Decreased, Fatigue, Chest Discomfort, Dyspnoea, Chest Pain

Drug(s) suspected as cause:
Chlorpheniramine TAB
    Dosage: 10 mg, unk, iv
    Indication: Product Used FOR Unknown Indication

Dexamethasone
    Dosage: 20 mg, iv
    Indication: Product Used FOR Unknown Indication

Dexamethasone
    Dosage: 4 mg, bid, po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Domperidone (Domperidone)
    Dosage: 20 mg, po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Granisetron
    Dosage: 1 mg, bid, po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Paclitaxel
    Dosage: 315;300 mg, qow, iv
    Indication: Breast Cancer
    Start date: 2011-05-24
    End date: 2011-07-05

Paclitaxel
    Dosage: 315;300 mg, qow, iv
    Indication: Breast Cancer
    End date: 2011-07-05

Pegfilgrastim (Pegfilgrastim)
    Dosage: 6 mg, sc
    Indication: Product Used FOR Unknown Indication

Ranitidine Hydrochloride
    Dosage: 50 mg, iv
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Biotene; Doxorubicin HCL; Cyclophosphamide; Docusate



Possible Paclitaxel side effects in 77 year old female

Reported by a physician from United States on 2012-06-22

Patient: 77 year old female, weighing 96.4 kg (212.1 pounds)

Reactions: White Blood Cell Count Decreased, Dyspnoea, Anaemia, Fall, HIP Fracture, Fatigue, Platelet Count Decreased, Neutrophil Count Decreased

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Avastin
    Dosage: last dos eprior to sae 22 feb 2012
    Indication: Ovarian Cancer
    Start date: 2012-02-01

Carboplatin
    Dosage: last dos eprior to sae 5 apr 2012
    Indication: Ovarian Cancer
    Start date: 2012-02-01

Paclitaxel
    Dosage: last dos eprior to sae 5 apr 2012
    Indication: Ovarian Cancer
    Start date: 2012-02-01



Possible Paclitaxel side effects in 48 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-22

Patient: 48 year old female, weighing 70.0 kg (154.0 pounds)

Reactions: Respiratory Depth Decreased, Chest Discomfort, Dyspnoea, Fatigue

Drug(s) suspected as cause:
Chlorpheniramine TAB
    Indication: Product Used FOR Unknown Indication

Dexamethasone

Dexamethasone
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Domperidone
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Granisetron
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Neulasta
    Indication: Chemotherapy

Paclitaxel
    End date: 2011-07-05

Paclitaxel
    Indication: Breast Cancer
    Start date: 2011-05-24
    End date: 2011-07-05

Ranitidine
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Cyclophosphamide; Docusate; Doxorubicin HCL; Biotene



Possible Paclitaxel side effects in 64 year old female

Reported by a physician from United States on 2012-06-21

Patient: 64 year old female, weighing 102.0 kg (224.4 pounds)

Reactions: Abdominal Pain, Soft Tissue Infection, Fatigue, Colonic Fistula, Hypermagnesaemia, Hyponatraemia, Hypoalbuminaemia, Disease Progression

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Avastin
    Indication: Ovarian Epithelial Cancer
    Start date: 2009-12-03

Carboplatin
    Indication: Ovarian Epithelial Cancer
    Start date: 2009-12-03

Paclitaxel
    Indication: Ovarian Epithelial Cancer
    Start date: 2009-12-03



Possible Paclitaxel side effects in 49 year old female

Reported by a pharmacist from United Kingdom on 2012-06-21

Patient: 49 year old female, weighing 70.0 kg (154.0 pounds)

Reactions: Respiratory Depth Decreased, Fatigue, Dyspnoea, Chest Discomfort, Chest Pain

Drug(s) suspected as cause:
Chlorphenamine
    Dosage: 10 mg, 1x/day
    Indication: Product Used FOR Unknown Indication

Dexamethasone
    Dosage: 20 mg, 1x/day
    Indication: Product Used FOR Unknown Indication

Dexamethasone
    Dosage: 4 mg, 2x/day
    Administration route: Oral

Domperidone
    Dosage: 20 mg, 1x/day
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Domperidone
    Dosage: 20mg, daily
    Administration route: Oral

Granisetron
    Dosage: 1 mg, 2x/day
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Paclitaxel
    Dosage: 315 mg, every two weeks
    Indication: Breast Cancer
    Start date: 2011-05-24
    End date: 2011-06-07

Paclitaxel
    Dosage: 300 mg, every 2 weeks
    Start date: 2011-06-21
    End date: 2011-07-05

Pegfilgrastim
    Dosage: 6 mg, 1x/day
    Indication: Chemotherapy

Ranitidine
    Dosage: 50 mg, 1x/day
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Docusate; Biotene Mouthwash



Possible Paclitaxel side effects in female

Reported by a physician from United States on 2012-06-19

Patient: female, weighing 68.7 kg (151.1 pounds)

Reactions: Fatigue, Pancytopenia, General Physical Health Deterioration, Failure To Thrive, Decreased Appetite, Enterocolitis Infectious

Adverse event resulted in: death

Drug(s) suspected as cause:
Paclitaxel
    Dosage: 73 mg wkly x 4 doses iv
    Indication: Glioblastoma Multiforme
    Start date: 2010-06-28

Paclitaxel
    Dosage: 73 mg wkly x 4 doses iv
    Indication: Glioblastoma Multiforme
    Start date: 2010-06-21

Paclitaxel
    Dosage: 73 mg wkly x 4 doses iv
    Indication: Glioblastoma Multiforme
    Start date: 2010-06-07

Paclitaxel
    Dosage: 73 mg wkly x 4 doses iv
    Indication: Glioblastoma Multiforme
    Start date: 2010-06-14

Temozolomide
    Dosage: 135 mg daily po
    Administration route: Oral
    Indication: Glioblastoma Multiforme
    Start date: 2010-06-07
    End date: 2010-06-30



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014